Building in Solutions for Anticipated Challenges in CAR T Development Programs

CAR T-cell therapies are fundamentally changing the landscape of cancer treatment. Successful commercialization of multiple CAR T treatments, plus continued advancements in the technologies, combine to make this a very active segment of drug development. Despite the excitement and hope they have brought to the patient and research communities, the sponsors developing these therapeutics are encountering challenges that have delayed and seriously threatened the advancement of their programs. These therapies require specialized sites, recruitment strategies and clinical development partners experienced in delivery of these complex programs.

In this webinar, attendees will hear from speakers partnering with the sponsors developing novel CAR T therapeutics. Their corporate and personnel experience in delivering these complex programs has armed them with the lessons learned to design current and future CAR T programs in anticipation of expected challenges. Register to hear these speakers address the most common challenges and questions they hear from their CAR T sponsors.

Register today for an informative overview of how to address the challenges arising in CAR T-cell development programs. Attendees are encouraged to bring their questions, notepad and colleagues to this webinar!

Speakers

Missy Green, MBA, Associate Director, Project Management, Worldwide Clinical Trials

Missy Green has more than nine years of clinical research experience, six years of which were in project management. She has a strong background in oncology, having worked on multiple clinical trials involving a broad range of solid tumor types, head and neck cancer, multiple myeloma, CAR T and radiopharmaceuticals. Prior to joining the CRO industry, Missy was a patient care technician at Rochester General Hospital in Rochester, New York, and a clinic coordinator for Children’s National Hospital in Washington, DC, USA. Missy has an MBA in healthcare administration and a bachelor’s degree in international relations.

Message Presenter

Jake Boyd, Director, Project Management, Oncology, Worldwide Clinical Trials

Jake Boyd has more than 10 years of clinical development project management experience, including in the development of innovative oncology products such as cell therapy, CAR T therapies, gene therapy and multiple immuno-oncology studies with biologics and small molecules. His experience encompasses Phase I to III, with specific emphasis in early phase work, including first-in-human and dose escalation/expansion studies. He is well-versed in leading small biotech and large pharma project teams to successfully achieve corporate milestones and progress through the phases of drug development. Jake has a BS in biology from East Carolina University.

Message Presenter

Amy Raymond, PhD, PMP, Senior Director, Therapeutic Strategy Lead, Rare Diseases, Worldwide Clinical Trials

Amy Raymond has been a drug discovery and development professional for 25+ years, including progressive roles in clinical operations and rare disease clinical strategy, and today leads the Gene Therapy Think Tank at Worldwide Clinical Trials. Her clinical development experience has focused on rare and complex diseases, especially development of cell and gene therapies. Amy completed her doctoral training in molecular biology at University of California San Diego and post-doctoral training in molecular biology at Memorial Sloan-Kettering.

Message Presenter

Daniel A. Perez, CCRP, Global Head, Patient Experience, Diversity & Inclusion, Worldwide Clinical Trials

Daniel Perez has worked in the healthcare and pharmaceutical industry for over 14 years, moving through various progressive roles in health administration, clinical operations, strategic business development and C-Suite executive management. To date he has led the implementation of over 40 early and late phase clinical trials, overseeing full cycle including protocol development, clinical operations, patient recruitment & retention, standard operating procedure & policy writing and regulatory strategy. Daniel graduated Summa Cum Laude with a bachelor’s degree from Southern California University of Health Sciences and received his certification of clinical research professional (CCRP) from the Society of Clinical Research Associates (SOCRA).

Message Presenter